Skip to content

Clinical Study on the Prevention and Control of Myopia in Adolescents by Combining Traditional Chinese and Western medicine

Clinical Study on the Prevention and Control of Myopia in Adolescents by Combining Traditional Chinese and Western medicine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000821
Enrollment
Unknown
Registered
2025-04-22
Start date
2024-04-20
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Integrated Traditional Chinese and Western medicine treatment group 1:Thumb-tack needle combined with 0.01% atropine eye drops
Integrated Traditional Chinese and Western medicine treatment group 2:Auricular acupressure combined with 0.01% atropine eye drops
Control group: 0.01% atropine eye drops
Integrated Traditional Chinese and Western medicine treatment group 3:Thumb-tack needle and auricular acupressure combined with 0.01% atropine eye drops

Sponsors

Eye & ENT Hospital Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1.Patients aged 7-14 years; 2.Patients meet the diagnostic criteria of simple myopia: blurred distant vision under normal adjustment good near-distance vision; the image is myopic ametropia which can be corrected by negative spherical lens (or with negative column lens). The degree of myopia is low; The visual function of other eyes is basically normal; 3.Patients' diopter number after ciliary muscle paralysis: -0.50D < SE=-3.00D; 4.Patients participate in the study voluntarily with good compliance and their guardian signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients combined with other eye diseases (cataract congenital retinal disease strabismus amblyopia etc.) and systemic diseases; 2. Patients with active eye lesions or eye surgery; 3. Patients are allergic to atropine; 4. Patients with local acupoint skin damage inflammation and tape allergy; 5. The guardian has unreasonable expectations.

Design outcomes

Primary

MeasureTime frame
Axial length;Spherical equivalent;

Secondary

MeasureTime frame
Choroidal blood flow;Uncorrected visual acuity;Retinal blood flow;Len thickness;Choroidal thickness;Retinal thickness;Anterior chamber depth;

Countries

China

Contacts

Public ContactZhou Xingtao

Eye& ENT Hospital Fudan University

doczhouxingtao@163.com13816880725

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026